95368 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups - in which the condensed system contains three hetero rings Bridged systems
GLP-1 RECEPTOR AGONISTS AND METHODS OF USE
#22-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
#3KIF MODULATOR COMPOUNDS AND METHODS OF USE
#4FUSED RING COMPOUND HAVING GLP-1 RECEPTOR AGONIST EFFECT
#5NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE
#6GPR65 MODULATORS
#7IBOGAINE COMPOUNDS FOR TREATING BRAIN DISORDERS
#8SMALL MOLECULES AS KCNQ2/3 (KV7.2/3) CHANNEL ACTIVATORS AND THEIR MEDICAL USE THEREOF
#9ENHANCED PERFORMANCE OF AMORPHOUS SOLID AND SOLUBILIZED FORMULATIONS FOR ACHIEVING THERAPEUTIC PLASMA CONCENTRATIONS
#10BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF
#111,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF
#12INHIBITORS OF KIF18A AND USES THEREOF
#13Nitrogen-Containing Heterocyclic Compounds
#14Substituted tricyclic ligands for FK506-binding proteins for treatment of diseases
#15HETEROCYCLIC GLP-1R AGONISTS
#16METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
#17SOLID FORMS OF HIV INTEGRASE INHIBITORS
#18MACROCYCLIC COMPOUNDS AND USES THEREOF
#19SOLID FORMS OF HIV INTEGRASE INHIBITORS
#20METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
#21POLYCYCLIC CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR TREATING OR PREVENTING INFLUENZA
#22Varenicline Related Compounds and Methods for Treating Diseases and Conditions Including Tobacco Use Disorder
#23HEXAHYDROPYRIDO[4,3-B]INDOLYL KETONE DERIVATIVES USEFUL AS CGAS MODULATORS
#24PROTEASOME ENHANCERS AND USES THEREOF
#251,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF
#26PRODUCTION METHOD FOR T CELLS OR NK CELLS, MEDIUM FOR CULTURING T CELLS OR NK CELLS, METHOD FOR CULTURING T CELLS OR NK CELLS, METHOD FOR MAINTAINING UNDIFFERENTIATED STATE OF UNDIFFERENTIATED T CELLS, AND GROWTH-ACCELERATING AGENT FOR T CELLS OR NK CELLS
#27OPIOID RECEPTOR MODULATORS
#28BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF
#29BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#30TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF
#31MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF
#32ANTI-VIRAL COMPOUNDS
#33TRICYCLIC GPR65 MODULATORS
#34POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE
#35Monoacylglycerol Lipase Modulators
#364-SUBSTITUED CYTISINE ANALOGUES
#37BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF
#38PRODRUGS OF 6-DIAZO-5-OXO-L-NORLEUCINE
#39POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#40COMPOUNDS
#41WEE1 INHIBITORS AND USES THEREOF
#42GPR119 AGONISTS
#43NOVEL TETRAHYDROISOQUINOLINE ALKALOID COMPOUND CONTAINING MACROCYCLE
#44SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#45HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING
#46HDAC6 INHIBITORS AND USES THEREOF
#47Compounds and Their Use as PDE4 Activators
#48FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
#49TYK2 inhibitors and compositions and methods thereof
#50NLRP3 MODULATORS
#51MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF
#52CONOLIDINE ANALOGUES AS SELECTIVE ACKR3 MODULATORS FOR THE TREATMENT OF CANCER
#53N-(PYRIDIN-2-YL)-6,7,8,9-TETRAHYDRO-5H-5,8-EPIMINOCYCLOHEPTA[C]PYRIDINE-10-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS GPR65 MODULATORS FOR THE TREATMENT OF CANCER
#54MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES
#55NOVEL INDIRUBIN DERIVATIVES HAVING HETEROBICYCLIC MOIETIES AND THE USE THEREOF
#56QUINAZOLINE COMPOUND AND APPLICATION THEREOF
#57TETRAHYDROISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF RED BLOOD DISORDERS AND INFLAMMATORY DISEASES
#58Ibogaine-related compounds and corresponding methods
#59Vareniciline compound and process of manufacture thereof
#60Vareniciline compound and process of manufacture thereof
#61VARENICLINE COMPOUND AND PROCESS OF MANUFACTURE THEREOF
#62Opioid receptor modulators
#63Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
#64Monoacylglycerol lipase modulators
#65Polycyclic carbamoylpyridone derivative
#66INHIBITORS OF KRAS G12C PROTEIN AND USES THEREOF
#67ENDOCYCLIC PYRIMIDINONE COMPOUNDS, AND PREPARATION METHODS, COMPOSITIONS AND USE THEREOF
#68Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
#694-substitued cytisine analogues
#70NLRP3 MODULATORS
#71MACROCYCLIC JAK INHIBITOR AND USE THEREOF
#72CRYSTALLINE FORMS OF (9R, 135S)-13- {4-[5-CHLORO-2-(4-CHLORO-1H,2,3- TRIAZOL- 1 -YL)PHENYL] -6-OXO- 1,6-DIHYDROPYRIMIDIN- 1-YL}-3-(DIFLUOROMETHYL)-9-METHYL-3,4,7,15- TETRAAZATRICYCLO [ 12.3.1.0 2·6] OCTADECA- 1(18), 2(6), 4, 14, 16-PENTAEN-8-ONE
#73Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
#74POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#75MACROCYCLES AS FACTOR XIA INHIBITORS
#76MONOMER AND MULTIMERIC ANTI-HBV AGENTS
#77Method for Isolation of Cytisine
#78Tridentate macrocyclic compounds
#79Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
#80BRIDGED CYCLOFORMYLPYRIDINE DERIVATIVES AND USES THEREOF
#81MACROCYCLIC FLU ENDONUCLEASE INHIBITORS
#82CYTISINE SALTS
#83Monoacylglycerol lipase modulators
#84Spirocyclic lactams as JAK2 V617F inhibitors
#85MACROCYCLIC DERIVATIVES AS FACTOR XIA INHIBITORS
#86Varenicline compound and process of manufacture thereof
#87Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections
#88Macrocyclic derivatives acting as XIa factor inhibitor
#893,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-c]pyridine compounds and medicaments using same
#90HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C
#91NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE
#92ENHANCED PERFORMANCE OF AMORPHOUS SOLID AND SOLUBILIZED FORMULATIONS FOR ACHIEVING THERAPEUTIC PLASMA CONCENTRATIONS
#93BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF
#94Macrocyclic compound and use thereof
#95PYRIMIDINONES AS FACTOR XIA INHIBITORS
#96Production method for T cells or NK cells, medium for culturing T cells or NK cells, method for culturing T cells or NK cells, method for maintaining undifferentiated state of undifferentiated T cells, and growth-accelerating agent for T cells or NK cells
#97Inhibitors of GLI1 as therapeutic agents
#98PIPERAZINYL AND PIPERIDINYL QUINAZOLIN-4(3H)-ONE DERIVATIVES HAVING ACTIVITY AGAINST PAIN
#99Aminopyrimidinyl derivatives
#100Ibogaine-related compounds and corresponding methods
#101MORPHINAN DERIVATIVE
#102Fused pentacyclic imidazole derivatives as modulators of TNF activity
#103Tricyclic heterocycle compounds useful as HIV integrase inhibitors
#104Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
#105Pyrazolopyridine compounds for the treatment of autoimmune disease
#106Method for isolation of cytisine
#107NLRP3 modulators
#108Compounds and compositions for the treatment of cystic fibrosis
#109Heterocyclic compounds and their use in preventing or treating bacterial infections
#110Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
#1113,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same
#112Fused pentacyclic imidazole derivatives
#113Macrocyclic deaza-purinones for the treatment of viral infections
#114Polycyclic carbamoylpyridone derivative
#115Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections
#116Macrocyclic ligands with pendant chelating moieties and complexes thereof
#117Calpain modulators and therapeutic uses thereof
#118Compounds and compositions for the treatment of cystic fibrosis
#119Method for isolation of cytisine
#120Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
#121HDAC6 inhibitors, with improved solubility and their uses
#122Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections
#123Pyrimidine derivative compound, pharmaceutically acceptable salt thereof, preparation process thereof, and pharmaceutical composition using the same
#124Cytisine salts
#125Biheteroaryl compounds and uses thereof
#1264-substitued cytisine analogues
#127BIHETEROARYL COMPOUNDS AND USES THEREOF
#128Compounds and methods for treating bacterial infections
#129Methods for preparing bis-tetrahydroisoquinoline-containing compounds
#130Reinforced macrocyclic ligands, complexes thereof, and uses of same
#131Macrocyclic ligands with picolinate group(s), complexes thereof and also medical uses thereof
#132Monoacylglycerol Lipase Modulators
#133Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof
#134Macrocycles as factor XIA inhibitors
#135Pyrimido-diazepinone compounds and methods of treating disorders
#136Macrocyclic ligands with pendant chelating moieties and complexes thereof
#137Synthesis of NIR fluorescent probe
#138Pyrimidinones as factor XIA inhibitors
#139Nanohoop compound embodiments comprising meta-substitution and molecular systems comprising the same
#140Compositions and methods for making terpenoid indole alkaloids
#141Fused pentacyclic imidazole derivatives
#142Macrocyclic deaza-purinones for the treatment of viral infections
#143Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#144Beta-lactamase inhibitors
#145Substituted dipyrido[1,2-a:1′,2′-d]pyrazines for treating viral infections
#146Therapeutic compound for pain and synthesis thereof
#147Polycyclic compound and organic electroluminescence device including the same
#148Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections
#149Pyrimido-diazepinone compounds and methods of treating disorders
#150Methods for preparing bis-tetrahydroisoquinoline-containing compounds
#151POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#152Macrocylic ligands with picolinate group(s), complexes thereof and also medical uses thereof
#153Therapeutic compounds for pain and synthesis thereof
#154Therapeutic compounds for pain and synthesis thereof
#155Therapeutic compounds for pain and synthesis thereof
#1562,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents
#157Macrocyclic factor XIa inhibitors bearing heterocyclic groups
#158Macrocyclic ligands with pendant chelating moieties and complexes thereof
#159Pyrimidinones as factor XIa inhibitors
#160Tricyclic modulators of TNF signaling
#161Polycyclic indoline and indolenine compounds
#162BIHETEROARYL COMPOUNDS AND USES THEREOF
#163Heterocyclic compounds and their use in preventing or treating bacterial infections
#164BIHETEROARYL COMPOUNDS AND USES THEREOF
#165Beta-lactamase inhibitors
#166SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
#167Indole and indoline derivatives and methods of use thereof
#168Macrocycles as factor XIa inhibitors
#169Imidazole derivative used as antiviral agent and use thereof in preparation of medicament
#170Substituted bridged urea analogs as sirtuin modulators
#171SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
#172Substituted bridged urea analogs as sirtuin modulators
#173MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES
#174Opioid receptor modulators
#175Fused pentacyclic imidazole derivatives
#176Pyrimido-diazepinone compounds and methods of treating disorders
#177ERK inhibitors
#178Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infections
#179HDAC6 inhibitors and their uses
#180Macrocyclic inhibitors of flaviviridae viruses
#181Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
#182Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
#183Azamorphinan derivatives and use thereof
#184Macrocycles with aromatic P2′ groups as factor xia inhibitors
#185P2X7 modulators
#186Therapeutic compound for pain and synthesis thereof
#187Therapeutic compounds for pain and synthesis thereof
#188Therapeutic compounds for pain and synthesis thereof
#189Therapeutic compounds for pain and synthesis thereof
#190Therapeutic compounds and synthesis
#191MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES
#192MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS
#193Donor-acceptor nanohoop compounds and methods of making and using the same
#194PYRIMIDINONES AS FACTOR XIA INHIBITORS
#195Macrocycles as factor XIa inhibitors
#196Dihydropyridone P1 as factor XIa inhibitors
#197Imidazole derivative used as antiviral agent and use therof in preparation of medicament
#198Pyridone-sulfone morphinan analogs as opioid receptor ligands
#199Macrocyclic deaza-purinones for the treatment of viral infections
#200Tricyclic modulators of TNF signaling
#201Organic Electroluminescent materials and devices
#202Heterocyclic compounds
#203POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#204Electrochromic iptycenes
#205Pyrimidinones as factor XIa inhibitors
#206Substituted bridged urea analogs as sirtuin modulators
#207Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them
#208Biheteroaryl compounds and uses thereof
#209P2X7 modulators
#210Pyrimido-diazepinone compounds and methods of treating disorders
#211INDOLE AND INDOLINE DERIVATIVES AND METHODS OF USE THEREOF
#212Pyrido[4,3-B]indole and pyrido[3,4-B]indole derivatives and methods of use
#213COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION
#214PROCESS FOR PRODUCING OPTICALLY ACTIVE BICYCLIC UREA COMPOUND
#215Macrocyclic inhibitors of flaviviridae viruses
#216Production of polyketides and other natural products
#217Macrocycles as factor XIa inhibitors
#218Compounds and methods for treatment of hypertension
#219Hexahydrodiazepinoquinolines carrying a substituted alkyl radical
#220Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease
#221Pyridonemorphinan analogs and biological activity on opioid receptors
#222Dihydropyridone p1 as factor XIa inhibitors
#223Azaadamantane formate ester and process for preparing azaadamantane derivatives
#224AZAADAMANTANE DERIVATIVES AND METHODS OF USE
#225Substituted bridged urea analogs as sirtuin modulators
#226Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
#227Macrocycles as factor XIa inhibitors
#228THERAPEUTIC STRATEGY FOR TREATING AUTOIMMUNE AND DEGENERATIVE DISEASES
#229Substituted pyrido[1′,2′:4,5]pyrazino[1,2-a]azepines for treating viral infections
#230Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
#231Stereoselective total synthesis of noribogaine
#232Pyrido[3,4-b] indoles and methods of use
#233Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
#234Biheteroaryl compounds and uses thereof
#235Compounds and methods for treatment of hypertension
#236Azaadamantane formate ester and process for preparing azaadamantane derivatives
#2375,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators
#238Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
#239Pyridonemorphinan analogs and biological activity on opioid receptors
#240Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP)
#241Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
#242Nitrogen containing morphinan derivatives and the use thereof
#243Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
#244COMPOUNDS AND METHODS OF TREATING DIABETES
#245Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
#246PYRIDONE/HYDROXYPYRIDINE 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
#247Compounds and methods for treatment of hypertension
#248Bridged heterocyclic compounds and methods of use
#249Macrocyclic inhibitors of flaviviridae viruses
#250MACROCYCLIC INTEGRASE INHIBITORS FOR USE IN THE TREATMENT OF FELINE IMMUNODEFICIENCY VIRUS
#251Drug targets to overcome de novo drug-resistance in multiple myeloma
#252Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#253Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#254Pyrido[4,3-B]indoles and methods of use
#255Pyrido[3,4-B]indoles and methods of use
#256Bridged heterocyclic compounds and methods of use
#257Compounds and methods for treating diabetes
#258Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
#259Pyrido[4,3-B]indoles and methods of use
#260PYRIDO[4,3-B]INDOLES AND METHODS OF USE
#261Bridged heterocyclic compounds and methods of use
#262Bridged heterocyclic compounds and methods of use
#263PYRIDO [4,3-B] INDOLE AND PYRIDO [3,4-B] INDOLE DERIVATIVES AND METHODS OF USE
#264Stereoselective total synthesis of noribogaine
#265Sulfate esters of noribogaine
#266Azaadamantane derivatives and methods of use
#267Small molecule inhibitors of hepatitis C virus
#2684-aryl-2-anilino-pyrimidines
#269Compounds and methods of treating diabetes
#270Compounds and methods for treatment of hypertension
#271Bridged bicyclic heteroaryl substituted triazoles useful as inhibitors
#272Macrocycles as factor XIa inhibitors
#2734-SUBSTITUTED AZAADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF
#274ACETAMIDE AND CARBOXAMIDE DERIVATIVES OF AZAADAMANTANE AND METHODS OF USE THEREOF
#275AZAADAMANTANE ESTER AND CARBAMATE DERIVATIVES AND METHODS OF USE THEREOF
#276Macrocyclic integrase inhibitors
#277HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF
#278PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#279SPIROCYCLIC AZAADAMANTANE DERIVATIVES AND METHODS OF USE
#280Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
#281Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
#282Macrocycles as factor XIa inhibitors
#283AZINONE-SUBSTITUTED AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF
#284BRIDGED COMPOUNDS AS HIV INTEGRASE INHIBITORS
#285Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
#286Nuclear export inhibitors of topoisomerase II alpha
#287Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
#288Pyrido[4,3-b]indoles and methods of use
#289Pyrido[3,4-B]indoles and methods of use
#290NOVEL BRIDGED CYCLIC COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS
#291Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
#292Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase
#293Production of polyketides and other natural products
#294AZA-bridged ring-fused indoles and indolines
#295Bridgehead amine ring-fused indoles and indolines
#296Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT) modulators and uses thereof
#297Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
#298Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
#299Histamine H3 Inverse Agonists and Antagonists and Methods of Use Thereof
#300(Dihydro)pyrrolo[2,1-α]isoquinolines